Global Osseointegration Implants Market Overview
Osseointegration Implants Market Size was valued at USD 3.10 Billion in 2023. The Global Osseointegration Implants industry is projected to grow from USD 4.80 Billion in 2024 to USD 7.50 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.80% during the forecast period (2024 - 2032).
Technological innovation in the healthcare sector is assisting in the creation of highly efficient and innovative therapies that give speedier relief from a variety of medical ailments.
Osseointegration implants are utilized to create a direct functional and structural link between the bone and the surface of the artificial implant. With an expanding elderly population and the growing popularity of aesthetic dentistry.
The advancement of osseointegration technology has improved bone and joint replacement surgeries, as well as dental implants, and has improved prostheses for patients. The use of various materials to carry out the operation, as well as the capacity to offer stability to the implants and prostheses, is driving the growth of the worldwide osseointegration implant market.
iEXCEL, an advanced implant system by The Straumann Group, was pre-launched in October 2023. This aims at harmonizing apically and completely tapered implants including tissue level. It aims at giving a single connection so as to offer clinicians a unified prosthetic platform and streamlined digital workflow.
The next generation of dental implant systems was unveiled by Dentsply Sirona in 2023 under the name Astra Tech Implant System EV. This includes advances in surface technology that enable osseointegration to take place more effectively while maintaining esthetical aspects such as color matching.
Straumann Group, the parent company of Institut Straumann AG, on the other hand, purchased PlusDental in May 2022, aimed at enhancing its presence in states like Sweden, Netherlands and the UK through PlusDental clinics all over Europe. Such strategic acquisitions and collaborations strengthen key players’ market positions and expand their market reach, making it easier for more people to get osseointegration implants across Europe.
In February 2022, Zimmer Biomet Holdings, Inc., a medical device company, launched its new product line, OverdenSURE, for Zimmer Biomet dental implants used in both North America and Europe. It has an appealing zirconium nitride abutment coating that maintains aesthetics but also improves function. One advantage is that it provides various types of abutments, thus offering greater restorative possibilities. The classical design of the OverdenSURE system is intended to be user-friendly.
There have been significant advancements occurring in 2021 with respect to components used for implantation, such as newer titanium alloys and ceramics which took place recently (Lopez et al., 2019). These materials are stronger, last longer than previous ones did and do not cause any harm to organisms, leading to better patient outcomes than ever before.
During 2021, there has been increasing use of three-dimensional printing for creating osteo-integrating dental implants; it allows for much finer customization and accuracy. Therefore, many complex shapes and structures cannot be manufactured by traditional methods but can with this technology
Digital implant planning using computer-aided design (CAD) software and 3D imaging has become more popular in 2020 to plan implant placement and create surgical guides (Buser et al., 2020). Moreover, its use reduces surgical time and improves accuracy thus getting better results for the patients.
Osseointegration Implants Market Top Key Players
The key players operating in the Global Osseointegration Implants Market are
- Zimmer Biomet Holdings Inc.
- Dentsply Sirona Inc.
- Danaher Corporation
- The Straumann Group
- Henry Schein Inc.
- Stryker Corporation
- NuVasive, Inc.
- William Demant Holding A/S
- Cochlear Ltd.
- Medtronic plc.
Osseointegration Implants Market Segmentation
Osseointegration Implants Product Outlook
- Bone-anchored Prostheses
- Dental Implants
- Others
Osseointegration Implants Material Type Outlook
- Metallic
- Ceramic
- Polymeric
- Others
Osseointegration Implants End User Outlook
- Hospitals
- Ambulatory Surgical Clinics
- Others
Osseointegration Implants Regional Outlook
- Americas
- Europe
- Asia Pacific
- The Middle East and Africa
Recent Development
Zimmer Biomet Holdings, Inc. (Zimmer Biomet) is a musculoskeletal healthcare medical device firm. The firm develops, manufactures, and sells orthopedic reconstructive products; biologics; sports medicine; extremities; and trauma goods; spine, craniomaxillofacial, and thoracic products; office-based technologies; dental implants; and associated surgical products. Orthopedic surgeons, oral surgeons, neurosurgeons, other specialists, dentists, stocking distributors, hospitals, healthcare dealers, and healthcare buying groups are all served by Zimmer Biomet.
The Straumann Group, headquartered in Basel, Switzerland, studies, develops, produces, and distributes dental implants, tools, biomaterials, CADCAM prostheses, digital equipment, software, and clear aligners for use in replacement, restorative, orthodontic, and preventative dentistry. The Straumann Group also provides services to the dental profession across the world, such as training and education, in conjunction with the International Team for Implantology (ITI) and the Latin American Institute of Dental Research and Education.
Market Report Overview
The MRFR's research report offers a detailed and unbiased analysis of the key market trends in the global Osseointegration Implants Market. It includes a detailed discussion on the current as well as historical market dynamics, consumer landscape, competitive landscape, growth opportunities and challenges backed by fact-based feedbacks. The types of products that are covered in the report on the global osseointegration implants market are bone-anchored prostheses, dental implants and others. The primary material types assessed in the report are metallic, ceramic, polymeric and others. The end-users that are covered in the report on the global osseointegration market include hospitals, ambulatory surgical clinics and others. All the sub-markets that are covered in the report on the global osseointegration implants market are profiled under four major regions such as the Americas, Europe, Asia Pacific and the Middle East and Africa, along with country-level analysis.
Research Methodology
MRFR employs its industry expertise for the deliverance of qualitative and quantitative analysis of market trends, growth opportunities, consumer landscape and challenges in order to ensure the accuracy and authenticity of the market foresight. Primary and secondary research processes are utilized for data collection through surveys and interviews with key opinion makers across the value chain and verification of collected data through inputs from SEC filings, white paper references, paid databases and other credible sources available in public domain. Top-down and bottom-up approaches ensure the quality, accuracy and objectivity of the research findings.
Osseointegration Implants Market Highlights:
Frequently Asked Questions (FAQ) :
The osseointegration implants market is projected to grow at a 6.80% CAGR during the forecast period.
The osseointegration implants market is predicted to touch USD 7.50 billion during the forecast period.
The Americas is projected to command the largest share in the osseointegration implants market.
The hospitals segment will have the largest share in the osseointegration implants market.
Risk of bone damage may limit market growth.